Your Complete Policy Management Partner
Everything your healthcare organization needs to confidently maintain accreditation compliance.
Robust document control and workflow management software solution
Simplify & automate policy access, review and approval across your organization
Web-based library of more than 18,000 customizable policy documents
Instantly access up-to-date policies, procedures & forms authored by MCN experts
Automated regulatory notification system of daily email or mobile alerts
Keep current with regulatory changes from more than a dozen federal regulatory bodies, including TJC & NIAHO
What Our Customers are Saying
MCN Healthcare has been indispensable to our accreditation compliance efforts. With Policy Manager, Policy Library and StayAlert!, we have peace of mind that our policies will always be up-to-date and easy to locate.
Beverly McKenzie, Compliance Programs Director, IASIS Healthcare
Helpful MCN Healthcare Resources
Sandoz US is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer. Parenteral injection of drug from the affected lots can lead to microembolisation in areas where the particles lodge. Clinical symptoms are not to be expected from these microemboli and Sandoz is not aware of any reports of related adverse events.
Methotrexate is an antimetabolite used in the treatment of neoplastic diseases, severe psoriasis, and rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis. The lot numbers and expiration dates of the two recalled lots are: CL0996 (expiration date 12/2013) and CJ4948 (expiration date 05/2013). These lots were distributed nationally across the US and to a single foreign country (Poland).
In the event that a patient experiences an adverse reaction or quality problem involving this product, they should immediately contact their healthcare professional as well as Sandoz to report the finding. The Sandoz Drug Information Direct Line is open at 800-525-2492, 24 hours/day, seven days a week, or reports can be made via email at firstname.lastname@example.org.
Read the MedWatch alert, including a link to the Recall Notice, at the link below.
CMS Issues Categorical Life Safety Code Waiver Lowering Required Humidity Levels in Anesthetizing Locations
The Centers for Medicare & Medicaid Services (CMS) is issuing a categorical LSC waiver permitting new and existing ventilation systems supplying hospital and critical access hospital (CAH) anesthetizing locations to operate with a relative humidity (RH) of greater than or equal to 20 percent, instead of greater than or equal to 35 percent. CMS is also recommending that the RH not exceed 60 percent in these locations.
Hospitals and CAH should be aware that this waiver does not apply when more stringent RH control levels are required by State or local laws and regulations or where reduction in RH would negatively affect ventilation system performance.
Individual waiver applications are not required, but facilities are expected to have written documentation that they have elected to use the waiver. Further, at the entrance conference for any survey assessing LSC compliance, a facility that has elected to use this waiver must notify the survey team.
Facilities are required to monitor RH in anesthetizing locations and take corrective actions when needed to ensure RH remains at or above 20 percent.
Note that Ambulatory Surgical Centers (ASCs) are not subject to all of the same LSC requirements as hospitals, but are required, consistent with 42 CFR 416.44(a)(1), to maintain RH in operating rooms in accordance with nationally accepted guidelines.
The Centers for Disease Control and Prevention (CDC) has issued Guidance for Vaccinating Children during the 2013 Pentacel, Daptacel and Pediarix Shortages. in response to SanofiPasteur's Pentacel® (DTaP-IPV/Hib) and Daptacel® shortages and the reduced allocation of GlaxoSmithKline's Pediarix® vaccine. The shortages are expected to last throughout the summer of 2013.
The guidance encourages vaccine providers to:
- Continue to follow the recommended immunization schedule and ensure patient receive all recommended doses of DTaP, Hib, and polio vaccines.
- Search for alternative vaccines during the shortage (including single component DTaP, IPV, HepB, and Hib vaccines and other licensed combination vaccines which should be readily available).
- Contact your state and local immunization program for guidance about ordering vaccine if you participate in the VFC program.
See the Guidance Document, including possible scheduling scenarios and additional further information about vaccine shortages by following the link below.
Featured Policy Library Manuals
The Hazardous Materials and Waste Management Manual contains all the policies you need to meet hazardous material and waste management compliance. This manual is cross referenced to Joint Commission standards, NIAHO standards as well as OSHA Hazard Communication Standard 2012!Read more »
The Medical Office Policy and Procedure Manual is cross referenced to Joint Commission standards for Ambulatory Care and Primary Care Medical Homes and NCQA standards for Patient Centered Medical Homes. This manual includes policies that meet OSHA requirements for safety and infection control, Human Resources policies and Medical Office Compliance Plan and much more!Read more »
MCN Healthcare’s Comprehensive Long Term Care Manual contains over 600 policies and procedures that are cross-referenced to Joint Commission standards and CMS regulations. The LTC Manual addresses the following areas: Emergency Management, HR, Infection Control, Information Management, Leadership, Medication Management, Performance Improvement, Patient Care, Medical Records, Resident Rights and Waived TestingRead more »